posted on 2018-07-16, 08:13authored byRich Harrison, Aileen Gracias, William Mitchell
Research into cell and gene therapies is globally dispersed, which creates scientific opportunities, but in turn, significant commercial challenges. In order to successfully bring promising scientific endeavors through to commercial opportunity, greater cross-border coordination of supply side activity considerations such as academic institutions, funding gaps, intellectual property, and commercial entities as well as demand-side issues of reimbursement, regulatory policy, stakeholder engagement and patient engagement should be advocated for.
Funding
This study was supported by an EPSRC ETERM Landscape fellowship grant (RH) [grant number EP/I017801/1].
History
School
Aeronautical, Automotive, Chemical and Materials Engineering
Department
Chemical Engineering
Published in
Cell & Gene Therapy Insights
Volume
4
Issue
5
Pages
469 - 483
Citation
HARRISON, R., GRACIAS, A. and MITCHELL, W., 2018. Translating regenerative medicine science into clinical practice: the local to global pivot. Cell & Gene Therapy Insights, 4 (5), pp.469-483
Publisher
Bioinsights
Version
VoR (Version of Record)
Publisher statement
This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/
Acceptance date
2018-04-12
Publication date
2018
Notes
This is an Open Access Article. It is published by Bioinsights under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (CC BY-NC-ND). Full details of this licence are available at: http://creativecommons.org/licenses/by-nc-nd/4.0/